Core Viewpoint - The Hainan Provincial Drug Inspection Center is enhancing regulatory efficiency and industry service to support the rapid development of the pharmaceutical industry and the operation of the Hainan Free Trade Port, focusing on dual improvements in regulatory effectiveness and industry service [1] Regulatory Mechanisms - The center is actively transforming its regulatory approach to address limited resources and complex regulatory challenges, focusing on weak links in the pharmaceutical industry and expanding the scope and depth of inspections [2] - Key areas of focus include national procurement selected drug manufacturers, contract manufacturing enterprises, injectable drug producers, sterile and implantable medical device manufacturers, and children's cosmetics producers, ensuring comprehensive inspections [2][3] Risk Management - The center has developed a risk assessment framework that includes "three main lines" and two risk lists, allowing for detailed enterprise profiling and risk categorization [3] - This framework has led to the timely identification and resolution of potential risks, such as inadequate cleaning validation in production facilities and non-compliance with registered processes [3] Inspection Efficiency - The center has implemented measures to optimize inspection processes, reducing the burden on enterprises while maintaining safety standards [5][6] - In 2022, the center completed inspections for 1,804 entities, a 22.1% increase from the previous year, identifying 4,748 defects and enhancing regulatory deterrence [3] Service Improvement - The center is committed to improving its service system while upholding safety standards, providing support and guidance throughout the entire lifecycle of enterprises [8][9] - Initiatives include customized service activities, a dedicated WeChat column for common issues, and a "one-stop" pre-application mechanism to streamline compliance processes [8][9] Industry Development Support - The center is facilitating the implementation of the "Research and Use + Hainan Production" model by engaging with enterprises during the R&D and registration phases, offering targeted advice and support [9] - Continuous innovation in inspection mechanisms and service models is aimed at providing high-quality drug safety assurance for the construction of the Hainan Free Trade Port [9]